Su1348: EFFICACY, SAFETY, AND TOLERABILITY OF SELADELPAR IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS DUE TO PRIMARY BILIARY CHOLANGITIS (PBC); A POOLED ANALYSIS OF PHASE 2 AND PHASE 3 STUDIES
Stuart C. Gordon, Palak Trivedi, Christopher L. Bowlus, Michael Galambos, Aparna Goel, Aliya Gulamhusein, Cynthia Levy, Guy Neff, Carmen M. Stanca, Douglas Thorburn, …
Gastroenterology (New York, N.Y. 1943), Vol.162(7), p.S-1191
Su1348: EFFICACY, SAFETY, AND TOLERABILITY OF SELADELPAR IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS DUE TO PRIMARY BILIARY CHOLANGITIS (PBC); A POOLED ANALYSIS OF PHASE 2 AND PHASE 3 STUDIES
Creators
Stuart C. Gordon
Palak Trivedi
Christopher L. Bowlus
Michael Galambos
Aparna Goel
Aliya Gulamhusein
Cynthia Levy
Guy Neff
Carmen M. Stanca
Douglas Thorburn
Bruce R. Bacon
Brian B. Borg
Yvonne Doerffel
Lisa Forman
Bradley Freilich
Liliana Gheorghe
Maria Sarai Gonzalez-Huezo
Stephen A. Harrison
Jonathan C. Huang
Sook-Hayng Jeong
Seung-Up Kim
John Lake
Joseph Odin
Won Young Tak
Hillel Tobias
John M. Vierling
Ke Yang
Alexandra Steinberg
Yun-Jung Choi
Charles A. Mcwherter
Marlyn J. Mayo
Publication Details
Gastroenterology (New York, N.Y. 1943), Vol.162(7), p.S-1191
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hepatology